Analysts Have Conflicting Sentiments on These Real Estate Companies: Cushman & Wakefield (CWK) and Medical Properties Trust (MPT)
Analysts have been eager to weigh in on the Real Estate sector with new ratings on Cushman & Wakefield (CWK – Research Report) and Medical Properties Trust (MPT – Research Report).
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cushman & Wakefield (CWK)
In a report issued on February 20, Brendan Lynch from Barclays maintained a Hold rating on Cushman & Wakefield, with a price target of $19.00. The company’s shares closed last Friday at $13.33.
According to TipRanks.com, Lynch is ranked 0 out of 5 stars with an average return of
Cushman & Wakefield has an analyst consensus of Strong Buy, with a price target consensus of $19.00, representing a 45.3% upside. In a report issued on February 20, TipRanks – PerPlexity also downgraded the stock to Hold with a $14.00 price target.
See today’s best-performing stocks on TipRanks >>
Medical Properties Trust (MPT)
In a report issued on February 20, Michael Diana from Maxim Group reiterated a Buy rating on Medical Properties Trust, with a price target of $8.00. The company’s shares closed last Friday at $5.66.
According to TipRanks.com, Diana is a 3-star analyst with an average return of
Currently, the analyst consensus on Medical Properties Trust is a Hold with an average price target of $6.67, implying an 11.2% upside from current levels. In a report issued on February 19, Colliers Securities also maintained a Buy rating on the stock with a $7.00 price target.
